about
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace ...
Read More
3.72
0.32
(9.41%)
2.8M
XNAS Volume
XNAS 05 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Prime Medicine Inc is on 08 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Prime Medicine Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..